74 related articles for article (PubMed ID: 10880255)
1. Elevated plasma TGF-beta1 in renal diseases: cause or consequence?
Junker U; Haufe CC; Nuske K; Rebstock K; Steiner T; Wunderlich H; Junker K; Reinhold D
Cytokine; 2000 Jul; 12(7):1084-91. PubMed ID: 10880255
[TBL] [Abstract][Full Text] [Related]
2. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor beta 1 is significantly elevated in plasma of patients suffering from renal cell carcinoma.
Junker U; Knoefel B; Nuske K; Rebstock K; Steiner T; Wunderlich H; Junker K; Reinhold D
Cytokine; 1996 Oct; 8(10):794-8. PubMed ID: 8980881
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
[TBL] [Abstract][Full Text] [Related]
5. Serum transforming growth factor-beta1 in patients with renal cell carcinoma.
Wunderlich H; Steiner T; Junker U; Knöfel B; Schlichter A; Schubert J
J Urol; 1997 May; 157(5):1602-3. PubMed ID: 9112485
[TBL] [Abstract][Full Text] [Related]
6. Increased transforming growth factor beta1 plasma level in patients with renal cell carcinoma: a tumor-specific marker?
Wunderlich H; Steiner T; Kosmehl H; Junker U; Reinhold D; Reichelt O; Zermann DH; Schubert J
Urol Int; 1998 Aug; 60(4):205-7. PubMed ID: 9701731
[TBL] [Abstract][Full Text] [Related]
7. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
Summers AM; Coupes BM; Brennan MF; Ralph SA; Short CD; Brenchley PE
Nephrol Dial Transplant; 2005 Nov; 20(11):2427-32. PubMed ID: 16046504
[TBL] [Abstract][Full Text] [Related]
8. Nephromegaly relates to hepatocyte growth factor dysregulation in biliary atresia.
Tsau YK; Jou ST; Ni YH
Pediatr Nephrol; 2002 Jul; 17(7):554-9. PubMed ID: 12172775
[TBL] [Abstract][Full Text] [Related]
9. Plasma levels of transforming growth factor-beta1 in renal transplant recipients receiving different immunosuppressive regimens.
Citterio F; Pozzetto U; Romagnoli J; Tondolo E; Silvestri P; Nanni G; Castagneto M
Transplant Proc; 2004 Apr; 36(3):698-9. PubMed ID: 15110635
[TBL] [Abstract][Full Text] [Related]
10. [TGF-beta1 in allograft and long-term renal function].
Wang PX; Huang XY; Wang AJ; Huang CB; Fan MQ; Zhang YP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):700-3. PubMed ID: 16114562
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
Lin Y; Kikuchi S; Obata Y; Yagyu K;
J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
[TBL] [Abstract][Full Text] [Related]
12. Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.
Lario S; Mendes D; Bescós M; Iñigo P; Campos B; Alvarez R; Alcaraz A; Rivera-Fillat F; Campistol JM
Transplantation; 2003 May; 75(10):1647-54. PubMed ID: 12777850
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.
Park JY; Park MH; Park H; Ha J; Kim SJ; Ahn C
Tissue Antigens; 2004 Dec; 64(6):660-6. PubMed ID: 15546338
[TBL] [Abstract][Full Text] [Related]
14. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
Shimabukuro T; Ohmoto Y; Naito K
J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
[TBL] [Abstract][Full Text] [Related]
16. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
[TBL] [Abstract][Full Text] [Related]
17. Impact of renal denervation on renal content of GLUT1, albuminuria and urinary TGF-beta1 in streptozotocin-induced diabetic rats.
D'Agord Schaan B; Lacchini S; Bertoluci MC; Irigoyen MC; Machado UF; Schmid H
Auton Neurosci; 2003 Mar; 104(2):88-94. PubMed ID: 12648610
[TBL] [Abstract][Full Text] [Related]
18. [Expressions of transforming growth factor-beta1 and collagen IV in renal tissues of patients with chronic allograft nephropathy].
Han CX; Yu LX; Xu J; Xie QX; Wang YB; Deng WF; Liu XY; Zeng JH
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):567-9. PubMed ID: 15897139
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
20. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
